zolbetuximab
astellas
[]
$alpmy astellas to present positive findings from phase 3 spotlight trial of zolbetuximab during 2023 asco gi cancers sym... 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities